Lymphomas: pathogenesis, clinical features and diagnosis Lymphomas are some of the most common cancers in the UK, with a wide variation in disease progression and prognosis between subtypes.…
Support for Bill to allow terminal cancer patients access to drugs in development A private members Bill that seeks to allow doctors to prescribe investigational drugs to terminally ill cancer patients has won government backing.…
Public call for Roche to cut price of breast cancer drug An online petition calls on the drug company Roche to lower the price of its breast cancer drug Kadcyla to make it cheap enough to be made available on the NHS.…
Prostate cancer cells tricked into self-destruction because of their hunger for copper Researchers have found a way to utilise prostate cancer cells’ voracious appetite for copper as a weapon to kill them. …
Designated pharmacist to review procedures for trials of cancer drugs Changes to clinical trial procedures for new cancer drugs will prevent duplication, reduce bureaucracy and speed-up patient access to new products.…
‘Gene deserts’ are linked with breast cancer, research suggests Single-letter changes within long stretches of non-coding DNA affect how DNA loops together, physically interacting with target genes to influence their expression.…
Gene therapy: a treatment coming of age A decade ago many people had written off gene therapy altogether but now there are dozens of trials in progress around the world.…
Cancer drugs approved faster in the United States than in Europe or Canada Regulatory agencies in the United States take less time to approve new cancer drugs than those in Europe or Canada, according to new research.…
Clinical Pharmacist’s monthly news round-up: the top 10 in September 2014What has been happening in the world of pharmacy? Here’s our pick of must-read news from the past month……
E-cigarettes unhelpful for cancer patients, study suggests Study casts doubt on the effectiveness of electronic cigarettes as an aid to quit smoking.…